8 min ago | Medical News
Upsher-Smith Laboratories publishes data on Slo-Niacin and Lipitor combination study
Results of the SLIM Study were recently published in the Journal of Clinical Lipidology .
15 hrs ago | Business Wire
Public relations, press release distribution, investor relations, SEC filing
Pfizer has also developed a new che... NEW YORK-- --Pfizer Inc announced it has submitted pediatric data for Lipitor to the European Medicines Agency .
Lipitor, Vytorin Prove No Better Than Generic at Cutting Hospital Visits
Cholesterol pills Vytorin from Merck & Co. and Lipitor from Pfizer Inc. worked no better than simvastatin, a cheaper generic medicine, at keeping patients out of the hospital for heart attacks or stroke, a study found.
Niacin adds no benefit for statin patients: study
Taking the B vitamin niacin offers no additional benefit to seniors with coronary artery disease who are already prescribed cholesterol-lowering statin drugs, U.S. researchers say.
Niacin Adds No Benefit for Statin Patients: Study
Taking the B vitamin niacin offers no additional benefit to seniors with coronary artery disease who are already prescribed cholesterol-lowering statin drugs, U.S. researchers say.
Pfizer Inc Submits New Pediatric Data for Lipitor to EMEA
From EquityBites Health care company Pfizer Inc declared on Wednesday the submission of paediatric data for Lipitor to the European Medicines Agency .
Even The Pharaohs Needed Lipitor
Cardiologists have found hardened arteries in 3,500-year-old mummies. The pharaohs should have gone a little easier on the fatted calves.
Merck's Investigational Anacetrapib Phase IIb Study Results Presented ...
Nov 17, 2009 - In a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co-administered with atorvastatin, there were persistent lipid effects in the higher dose arms in both the monotherapy and co-administration treatment groups eight weeks after stopping active ...
FDA warns that heartburn drugs Prilosec, Nexium block benefits of blood thinner Plavix
Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.
New Data: Cholesterol Management Analysis of Upsher-Smith's...
Companies mentioned in this article: Upsher-Smith Laboratories, Inc. MAPLE GROVE, Minn., Nov.
Popular cholesterol drug may hurt, not help
A new study raises fresh concerns about Zetia and its cousin, Vytorin a ' drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.
Statins: Lowering Your Cholesterol
Statins are cholesterol-lowering medications that are highly effective and generally safe.
NicOx SA Announces NCX 6560 Meets Primary and Secondary Objectives in First-in- Man Study
NicOx S.A. today announced that a phase 1b, first-in-man study for NCX 6560, versus placebo and Lipitor? , has met its primary and secondary objectives.
Those with Heartburn Paying Too Much Green for Nexium 'Purple Pill' Says Consumer Reports
Report finds no one drug works better than another and all are relatively safe but some far more costly Nov.
Pfizer says absorbing Wyeth at top speed
Pfizer Inc Chief Executive Officer Jeffrey Kindler said the drugmaker is integrating its Wyeth purchase far faster than previous big acquisitions, and it will no longer be overly dependent on one or two blockbuster medications.
Statins may worsen symptoms in some cardiac patients
Although statins are widely used to prevent heart attacks, strokes, and other cardiovascular disorders, new research shows that the class of drugs may actually have negative effects on some cardiac patients.
Statins such as Lipitor and Zocor can damage your liver and kidneys
Although statins such as Lipitor and Zocor are widely used to prevent heart attacks, strokes, and other cardiovascular disorders, new research shows that the class of drugs may actually have negative effects on some cardiac patients.
The newest drugs may not always be the best
Last year pharmaceutical companies spent more than $4 billion urging patients like you to "ask your doctor" about their drugs.
Dr Reddy's develops generic version of Pfizer's Lipitor
Dr Reddy's Laboratories has succeeded in developing a copycat or generic version of Pfizer's Lipitor, the world's largest selling drug which has sales of over $10 billion.
Lipitor and Zocor: Are they equally effective?
Dr. Thomas Behrenbeck is a native of Germany, where he received his medical education at the Westfalian Wilhelm University in Munster and became board certified in internal medicine and cardiology.
Also on Topix